RESUMEN
PURPOSE: Choroidal melanoma (CM), a kind of malignant tumor, is the main type of Uveal melanoma and one half of CM patients develop metastases. As a member of Eph/ephrin pathway that plays vital role in tumors, EphrinA3 (EFNA3) has been proved to promote tumorigenesis in many tumors. But the effect of EFNA3 in CM has not been studied yet. Through inhibiting angiogenesis, inducing apoptosis and autophagy and so on, Artesunate (ART) plays a key anti-tumor role in many tumors, including CM. However, the exact mechanisms of anti-tumor in CM remain unclear. METHODS: The UALCAN and TIMER v2.0 database analyzed the role of EFNA3 in CM patients. Quantitative real time polymerase chain reaction (qPCR) and Western blot were used to detect the expression of EFNA3 in CM. The growth ability of CM was tested by clonogenic assay and Cell counting kit-8 assay, and the migration ability using Transwell assay. RESULTS: Our results found EFNA3 boosted CM cells' growth and migration through activating Stat3/Akt signaling pathway, while ART inhibited the tumor promoting effect of CM via downregulating EFNA3. In xenograft tumor model, EFNA3 knockdown and ART significantly inhibited tumor growth. CONCLUSION: EFNA3 could be a valuable prognostic factor in CM.
Asunto(s)
Melanoma , Neoplasias de la Úvea , Humanos , Animales , Melanoma/tratamiento farmacológico , Melanoma/genética , Artesunato/farmacología , Proteínas Proto-Oncogénicas c-akt , Carcinogénesis , Transformación Celular Neoplásica , Modelos Animales de Enfermedad , Transducción de SeñalRESUMEN
A CdS/reduced graphene oxide (RGO)/ZnO nanowire array (NWAs) heterostructure is designed, which exhibits enhanced photoelectrochemical (PEC) activity compared to pure ZnO, RGO/ZnO, and CdS/ZnO. The enhancement can be attributed to the synergistic effect of the high electron mobility of ordered 1D ZnO NWAs, extended visible-light absorption of CdS nanocrystals, and the formed type II band alignment between them. Moreover, the incorporation of RGO further promotes the charge carrier separation and transfer process due to its excellent charge collection and shuttling characteristics. Subsequently, the CdS/RGO/ZnO heterostructure is successfully utilized for the PEC bioanalysis of glutathione at 0 V (vs Ag/AgCl). The self-powered device demonstrates satisfactory sensing performance with rapid response, a wide detection range from 0.05 mm to 1 mm, an acceptable detection limit of 10 µm, as well as certain selectivity, reproducibility, and stability. Therefore, the CdS/RGO/ZnO heterostructure has opened up a promising channel for the development of PEC biosensors.
Asunto(s)
Técnicas Biosensibles/métodos , Compuestos de Cadmio/química , Técnicas Electroquímicas/métodos , Grafito/química , Luz , Nanocables/química , Sulfuros/química , Óxido de Zinc/química , Espectroscopía Dieléctrica , Electrodos , Glutatión/análisis , Nanocables/ultraestructura , Oxidación-Reducción , Espectroscopía de Fotoelectrones , Reproducibilidad de los Resultados , Espectrofotometría Ultravioleta , Espectroscopía Infrarroja por Transformada de FourierRESUMEN
We have realized the direct synthesis of ZnO nanorods (ZnO NRs) array on reduced graphene layer (rGO), and demonstrated the enhanced photoelectrochemical (PEC) property of the rGO/ZnO based photoanode under UV irradiation compared with the pristine ZnO NRs array. The introduction of the rGO layer resulted in a favorable energy band structure for electron migration, which finally led to the efficient photoinduced charge separation. Such nanostructure was subsequently employed for self-powered PEC biosensing of glutathione in the condition of 0 V bias, with a linear range from 10 to 200 µM, a detection limit of 2.17 µM, as well as excellent selectivity, reproducibility and stability. The results indicated the rGO/ZnO nanostructure is a competitive candidate in the PEC biosensing field.